Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study

SIMPLE SUMMARY: To assess the percentage of early breast cancer (EBC) patients treated with neoadjuvant systemic therapy (NAT) in Italy, criteria of patient selection and types of therapies delivered, 1276 stage I-II-III patients were enrolled and evaluated in the multicenter prospective observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Gori, Stefania, Fabi, Alessandra, Angiolini, Catia, Turazza, Monica, Salvini, Piermario, Ferretti, Gianluigi, Cretella, Elisabetta, Gianni, Lorenzo, Bighin, Claudia, Toss, Angela, Zamagni, Claudio, Vici, Patrizia, De Rossi, Costanza, Russo, Antonio, Bisagni, Giancarlo, Frassoldati, Antonio, Borgato, Lucia, Cariello, Anna, Cappelletti, Claudia, Bordonaro, Roberto, Cinieri, Saverio, Modena, Alessandra, Valerio, Matteo, Alvisi, Maria Francesca, De Simone, Irene, Galli, Francesca, Rulli, Eliana, Santoni, Anna, Nicolis, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572070/
https://www.ncbi.nlm.nih.gov/pubmed/37835546
http://dx.doi.org/10.3390/cancers15194852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572070/
https://www.ncbi.nlm.nih.gov/pubmed/37835546
http://dx.doi.org/10.3390/cancers15194852

Ejemplares similares